Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

pegbovigrastim

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Pegbovigrastim Treatment around Parturition Enhances Postpartum Immune Response Gene Network Expression of whole Blood Leukocytes in Holstein and Simmental Cows
Simple Summary The innate and adaptive immune system of dairy cows is impaired during the transition period, leading to an… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
2019
2019
Immunometabolic status and productive performance differences between periparturient Simmental and Holstein dairy cows in response to pegbovigrastim.
In the present study, we aimed to investigate the side effects of pegbovigrastim, injected approximately 7 d before parturition… Expand
2019
2019
Preliminary study on the effects of enrofloxacin, flunixin meglumine and pegbovigrastim on Mycoplasma bovis pneumonia
BackgroundMycoplasma bovis is a causative agent of disease in cattle causing many clinical conditions. Currently there are no… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2019
2019
Effect of pegbovigrastim administration on the microbiome found in the vagina of cows postpartum.
The objective of this study was to evaluate the effect of pegbovigrastim (PEG) treatment of peripartum Holstein cows on the… Expand
2019
2019
Effect of Pegbovigrastim on Hematological Profile of Simmental Dairy Cows during the Transition Period
Simple Summary During the transition period (TP), the innate and adaptive immune system of dairy cows is impaired, contributing… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
2018
2018
The effect of pegbovigrastim on circulating neutrophil count in dairy cattle: A randomized controlled trial
Previous research in various species has shown that granulocyte-colony stimulating factor stimulates the production and release… Expand
  • table 1
  • figure 1
2018
2018
Pegbovigrastim treatment affects gene expression in neutrophils of pasture-fed, periparturient cows.
Treatment with granulocyte colony-stimulating factor has been reported to increase circulating neutrophil count and enhance… Expand
2017
2017
Effect of prepartum energy balance on neutrophil function following pegbovigrastim treatment in periparturient cows.
Treatment with granulocyte colony-stimulating factor (G-CSF) increases polymorphonuclear cell (neutrophil) count and enhances… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
2017
2017
Efficacy and clinical safety of pegbovigrastim for preventing naturally occurring clinical mastitis in periparturient primiparous and multiparous cows on US commercial dairies.
Periparturient dairy cows experience impaired immune function, exhibited as a transient decrease in neutrophil function. This… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
2017
2017
Investigation of the effect of pegbovigrastim on some periparturient immune disorders and performance in Mexican dairy herds.
This study analyzed the efficacy of pegbovigrastim (Imrestor, Elanco Animal Health, Greenfield, IN) on some health and production… Expand
  • figure 1
  • figure 2
  • table 3
  • figure 3
  • table 2
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE